This article is from the web site listed below. This may give hope to many. Looks to be coming online in 2009...I sure hope so!
The next potential product in Durect's pipeline is Posidur, an injectable painkiller in late-stage testing. Unlike other painkillers that last a few hours, a single injection of Posidur is intended to last a few days.
The active ingredient is in a gel-like form, rather than a liquid. So Posidur breaks up and releases the active compound more gradually than a liquid, which dispenses quickly.
McAllister believes that Durect will launch Posidur in the second half of 2009. Durect will have to divide Posidur's European sales with its partner Nycomed. McAllister projected that Durect's portion of the sales for this drug will total $86 million in 2009, followed by $440 million in 2010, facing little or no competition.
"There are other companies that compete with [Durect] in terms of delivery technology," said McAllister. "But with Posidur specifically, there is very limited competition."
Co-Mod Fibromyalgia & Chronic Pain Forums
Fibromyalgia, Ulcerative Colitis, Insulin dependent diabetic, collapsed disk, dermatitis herpetiformus, osteo arthritis in spine and other locations.
The only difference between genius and stupidity is that genius has it's limits. Albert Einstein: (1879-1955)